Stock listing

NTRA Stock Price, News, Filings & Events — Natera, Inc.

Selected listing: NTRA · BX · CHF · CH

This page tracks Natera, Inc.'s NTRA:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NTRA:BX. NTRA:BX is the stock-level entry point for investors researching Natera, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Natera, Inc. is a publicly traded company listed under the ticker NTRA, operating in the American market. The company has a market capitalization of approximately $38.87 billion. Natera specializes in genetic testing and diagnostics, providing services that support reproductive health and oncology.

NTRA:BXCHFCHUpdated August 28, 2026
Natera, Inc. logo
Ticker
NTRA:BX
Asset type
Stock
Market cap
$47.03B
Sector
Health Technology
Industry
Biotechnology
Exchange
BX
Currency
CHF

Natera, Inc. NTRA:BX stock context

This page tracks Natera, Inc.'s NTRA:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NTRA:BX. NTRA:BX is the stock-level entry point for investors researching Natera, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Natera, Inc. is a publicly traded company listed under the ticker NTRA, operating in the American market. The company has a market capitalization of approximately $38.87 billion. Natera specializes in genetic testing and diagnostics, providing services that support reproductive health and oncology.

Latest news from Natera, Inc.

All Natera, Inc. news →

Natera, Inc. earnings calls

Research Natera, Inc.

Alternate listings